BAY 73-6691 racemate structure
|
Common Name | BAY 73-6691 racemate | ||
|---|---|---|---|---|
| CAS Number | 794568-90-4 | Molecular Weight | 356.73 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H12ClF3N4O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BAY 73-6691 racemateBAY 73-6691 racemate is a phosphodiesterase 9 inhibitor extracted from patent WO 2017070293 A1. |
| Name | BAY 73-6691 racemate |
|---|
| Description | BAY 73-6691 racemate is a phosphodiesterase 9 inhibitor extracted from patent WO 2017070293 A1. |
|---|---|
| Related Catalog | |
| Target |
phosphodiesterase 9[1] |
| References |
[1]. Liza Leventhal, et al. Phosphodiesterase 9 inhibitor and levodopa therapy. WO 2017070293 A1. |
| Molecular Formula | C15H12ClF3N4O |
|---|---|
| Molecular Weight | 356.73 |
| InChIKey | FFPXPXOAFQCNBS-UHFFFAOYSA-N |
| SMILES | CC(Cc1nc2c(cnn2-c2ccccc2Cl)c(=O)[nH]1)C(F)(F)F |
| Storage condition | 2-8℃ |